Evidence map›Paper›PMID 25977263›Full record

ArticleThe Journal of infectious diseases2015

Toll-like Receptor 10 in Helicobacter pylori Infection.

Hiroyuki Nagashima, Shun Iwatani, Modesto Cruz, José A Jiménez Abreu, Tomohisa Uchida, Varocha Mahachai, Ratha-Korn Vilaichone, David Y Graham, Yoshio Yamaoka

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 2 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 2 syntheses or guidelines pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Updates on Toll-Like Receptor 10 Research.European journal of immunology · 2025
    Review
  12. Article
  13. Review
  14. Review
  15. The immunopathogenesis ofFrontiers in microbiology · 2024
    Review
  16. Implications of lncRNAs inFrontiers in cellular and infection microbiology · 2024
    Review
  17. Essential role ofInfection and immunity · 2023
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 5 countries.

Hiroyuki NagashimaDepartment of Environmental and Preventive Medicine Department of Medicine-Gastroenterology, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas.
Shun IwataniDepartment of Environmental and Preventive Medicine Department of Medicine-Gastroenterology, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas.
Modesto CruzInstitute of Microbiology and Parasitology, Department of Science, Autonomous University of Santo Domingo Department of Biomedical Research, School of Medicine, Santiago Technological University.
José A Jiménez AbreuDominican-Japanese Digestive Disease Center, Dr Luis E. Aybar Health and Hygiene City, Santo Domingo, Dominican Republic.
Tomohisa UchidaDepartment of Molecular Pathology, Oita University Faculty of Medicine, Yufu, Japan.
Varocha MahachaiGastroenterology Unit, Department of Medicine, Thammasat University Hospital, Pathumthani.
Ratha-Korn VilaichoneDepartment of Gastroenterology, Bangkok Hospital, Thailand.
David Y GrahamDepartment of Medicine-Gastroenterology, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas.
Yoshio YamaokaDepartment of Environmental and Preventive Medicine Department of Medicine-Gastroenterology, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas.
Baylor College of Medicine · USMichael E. DeBakey VA Medical Center · USBangkok Hospital · THOita University · JPThammasat University Hospital · THUniversidad Tecnológica de Santiago · DO

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI James Versalovic · 2001 to 2026
$28.3M
REGULATION OF CXC CHEMOKINE EXPRESSION BY H. PYLORIR01DK062813 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI YAMAOKA, YOSHIO · 2004 to 2013
$3.0M
NIDDK NIH HHS DK56338NIDDK NIH HHS DK62813NIDDK NIH HHS P30 DK056338NIDDK NIH HHS R01 DK062813
6 · The paper itself

Abstract

Innate immunity plays important roles in the primary defense against pathogens, and epidemiological studies have suggested a role for Toll-like receptor 1 (TLR1) in Helicobacter pylori susceptibility. Microarray analysis of gastric biopsy specimens from H. pylori-positive and uninfected subjects showed that TLR10 messenger RNA (mRNA) levels were upregulated approximately 15-fold in infected subjects; these findings were confirmed by real-time quantitative polymerase chain reaction analysis. Immunohistochemical investigation showed increased TLR10 expression in the gastric epithelial cells of infected individuals. When H. pylori was cocultured with NCI-N87 gastric cells, both TLR10 and TLR2 mRNA levels were upregulated. We compared the ability of TLR combinations to mediate nuclear factor-κB (NF-κB) activation. Compared with other TLR2 subfamily heterodimers, the TLR2/TLR10 heterodimer mediated the greatest NF-κB activation following exposure to heat-killed H. pylori or H. pylori lipopolysaccharide. We conclude that TLR10 is a functional receptor involved in the innate immune response to H. pylori infection and that the TLR2/TLR10 heterodimer functions in H. pylori lipopolysaccharide recognition.

Indexed as

Cell LineCoculture TechniquesEpithelial CellsGastric MucosaGene Expression ProfilingHelicobacter InfectionsHelicobacter pyloriHumansImmunohistochemistryLipopolysaccharidesMicroarray AnalysisNF-kappa BReal-Time Polymerase Chain ReactionToll-Like Receptor 10Up-RegulationLipopolysaccharidesNF-kappa BTLR10 protein, humanToll-Like Receptor 10Helicobacter pyloriH. pylori LPSinnate immunityTLR10TLR2/TLR10 heterodimer

Identifiers

PMID25977263
PMCPMC4621249
OpenAlexW1962077068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.